HIGHLIGHTS
- who: Yuko Kanbayashi and colleagues from the Pharmaceutical University, Takatsuki, Japan, Department of Pharmacy, Seirei Hamamatsu General have published the research work: Factors associated with non-response to naldemedine for opioid-induced constipation in cancer patients: A subgroup analysis, in the Journal: PLOS ONE of May/21,/2022
- what: Details of the Rome IV diagnostic criteria used for the diagnosis of OIC in this study have been published previously . The results of this study showed that OIC was poorly controlled when taxane chemotherapy was administered within 1 month of evaluation of the naldemedine effect or . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.